Company profile: e+CancerCare
1.1 - Company Overview
Company description
- Provider of integrated cancer care through diagnostic testing, cancer imaging, radiation oncology (including IMRT and IGRT), medical oncology (chemotherapy and drug therapies), and patient support services, plus urology care with minimally invasive surgery. Founded in 2002, operates 24 clinically advanced outpatient cancer centers in ten states.
Products and services
- Cancer Imaging: Diagnostic-grade
- Produces cancer imaging for accurate diagnosis and treatment planning, supporting radiation and medical oncology across diagnostic testing within an integrated continuum of care
- Medical Oncology: Protocol-driven
- Delivers chemotherapy and other drug therapies to manage and treat cancer, aligning treatment plans with diagnostic testing and ancillary services in an integrated continuum of care
- Radiation Oncology Services: Clinically advanced
- Engineers cancer treatment using Intensity-Modulated Radiation Therapy (IMRT) and Image-Guided Radiation Therapy (IGRT) to target and treat tumors with precision and image guidance
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to e+CancerCare
Shields
HQ: United States
Website
- Description: Provider of MRI, radiation oncology (RO), CT, and PET/CT imaging services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Shields company profile →
Borrego Health
HQ: United States
Website
- Description: Provider of comprehensive primary health care and social services, offering main care, pediatric care, dental, behavioral, specialty care, and chiropractic treatments, with a focus on disadvantaged populations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Borrego Health company profile →
Stat Health
HQ: United States
Website
- Description: Provider of urgent care on Long Island through walk-in medical centers delivering timely, cost-effective urgent and routine medical care in a convenient, comfortable setting. Founded in 2005 by Dr. Paolo Coppola and Dr. Marc Salzberg, both Board Certified in Emergency Medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stat Health company profile →
APDerm
HQ: United States
Website
- Description: Provider of comprehensive, integrated dermatology services via a team of 30 clinical providers across 10 clinical offices in Massachusetts and New Hampshire; founded in 1992, the organization strives to deliver exceptional dermatologic care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full APDerm company profile →
Spine Nevada
HQ: United States
Website
- Description: Provider of comprehensive spine and musculoskeletal care in Reno, Nevada, with centers featuring fellowship-trained neurological surgeons, spine specialists board-certified in physical medicine and rehabilitation, interventional radiologists, specialty-trained physical therapists, and physical therapy clinics, addressing spine, back, neck, and joint conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spine Nevada company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for e+CancerCare
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to e+CancerCare
2.2 - Growth funds investing in similar companies to e+CancerCare
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for e+CancerCare
4.2 - Public trading comparable groups for e+CancerCare
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →